These experiments suggest that Gas6 is sufficient to promote the regrowth of gemcitabine-treated pancreatic cancer cells not only in PDAC cell lines in vitro, but also in patient-derived metastatic liver samples ex vivo. Here, GAS6 is linked to familial pancreatic carcinoma.